Rodman & Renshaw acted as a co-placement manager for Forte Biosciences, Inc. (NASDAQ: FBRX) follow-on offering. The $53 million private placement was announced on November 20th, 2024, and was led by OrbiMed, Janus Henderson Investors, Tybourne Capital Management, Alger, Ikarian Capital, LLC, BVF Partners LP, and The Red Hook Fund LP. To learn more about the transaction and Forte Biosciences, Inc., feel free to contact us at info@rodm.com”
About us
Rodman & Renshaw LLC (“Rodman") is a full service Investment Bank based in New York City. With over 70 years of heritage serving the middle market, Rodman is committed to fostering the long-term success of growth companies through strategic capital raising, investment banking, equity research and corporate access, all powered by our technologically driven electronic Equity Capital Markets (eECM) Platform, StockBlock.
- Website
-
https://www.rodm.com/
External link for Rodman & Renshaw
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 1951
Locations
-
Primary
600 Lexington Ave
32nd Floor
New York, NY 10022, US
Updates
-
Rodman & Renshaw acted as the exclusive placement agent for Monopar Therapeutics, Inc. (NASDAQ: MNPR) follow-on offering. The $19.2 million confidentially marketed public offering was priced on October 28th, 2024 and was led by Janus Henderson Investors, RA Capital Management, L.P. and other notable growth and life science investors. To learn more about the transaction and Monopar Therapeutics, Inc., feel free to contact us at info@rodm.com
-
-
Rodman & Renshaw acted as the exclusive placement agent for Richtech Robotics (NASDAQ: RR) follow-on offering. The $21 million upsized raise closed on September 3rd, 2024. To learn more about the transaction and Richtech Robotics, please feel free to contact us at info@rodm.com
-